middle.news
How Will LTR Pharma’s New US Advisors Accelerate ROXUS Launch?
8:59am on Wednesday 29th of October, 2025 AEDT
•
Healthcare
Read Story
How Will LTR Pharma’s New US Advisors Accelerate ROXUS Launch?
8:59am on Wednesday 29th of October, 2025 AEDT
Key Points
ROXUS development milestones on track for H1 2026 US launch
Appointment of leading US erectile dysfunction specialists to Scientific Advisory Board
Peer-reviewed study confirms SPONTAN’s fivefold faster onset versus oral tablets
100% patient satisfaction in post-prostatectomy ED cases presented at major conference
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
LTR PHARMA (ASX:LTP)
OPEN ARTICLE